Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First-Line Docetaxel: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (SAKK 08/11)Richard Cathomas, Silke Gillessen, Michael Mark et al.|The Prostate|2016Cited by 20